基层医疗中慢性病管理药物精简的系统综述:随机对照试验
该研究系统综述了基层医疗中慢性病与精神疾病管理的药物精简随机对照试验,共纳入58篇文章。最成功的干预为药师主导的教育干预和患者个体化用药建议;心血管药物最常被成功精简,精神药物和质子泵抑制剂最难精简。药物精简可能有效,但需密切临床随访,且未必改善跌倒、认知或生活质量。
要点
- 药师主导教育加个体化用药建议是药物精简最成功的干预策略。
- 心血管药物(降压药/利尿剂、硝酸酯类)最常被成功精简。
- 精神药物和质子泵抑制剂即使强化干预也难以精简。
核心结论
- 与标准照护相比,药物精简在特定药物类别中可能成功且有效,但需临床药师协作、个体化用药建议和密切临床随访以发现慢性病加重的早期征象。
研究设计与样本
- 系统综述,检索PubMed、Medline、EMBASE、Cochrane Library、Scopus和Web of Science,纳入58篇随机对照试验,研究对象为18岁及以上非终末期成人,涵盖门诊、辅助生活、养老院和急性照护机构。
主要发现
- 最成功的干预为药师主导的教育干预和患者个体化用药建议。
- 心血管药物(包括降压药/利尿剂和硝酸酯类)是最常被成功精简的药物类别。
- 精神药物和质子泵抑制剂即使接受强化干预也最难精简。
- 药物精简可能需昂贵、密集且持续的团队干预,未必改善跌倒率、认知、生活质量或降低入院率,并可能出现影响生活质量的非预期不良结局。
关键数值与推荐
- 主要结局为成功药物精简,定义为干预组与标准照护或对照组之间药物负担有统计学显著降低,或研究结束时干预组超过50%受试者能耐受停药而对照组不能。
临床怎么用
- 在基层医疗中对特定药物类别可尝试药物精简,建议临床药师参与患者和提供者教育并给出个体化用药建议。
- 药物精简期间需密切临床随访以早期发现慢性病加重征象。
- 对精神药物和质子泵抑制剂精简难度大,应预期强化干预也可能难以奏效。
- 不应仅以改善跌倒、认知、生活质量或降低入院率作为药物精简的必然预期获益。
局限性
- 研究时长从4周至5年不等,异质性较大。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Perform a systematic review to evaluate the outcome of deprescription compared with standard care. The focus was on chronic medical and mental health conditions managed in primary care. DESIGN: The databases searched include PubMed, Medline, EMBASE, the Cochrane Library, Scopus, and Web of Science. Each study was assessed for bias with the Cochrane Collaboration tool. SETTINGS AND PARTICIPANTS: This review included outpatient, assisted living, nursing home, and acute care settings (if medications for chronic disease were deprescribed). Subjects were non-terminally ill adults 18 years and older. MEASURES: Primary outcome was successful deprescription, defined as a statistically significant reduction in medication burden between the intervention group and the standard care or control group, or when more than 50% of intervention subjects were able to tolerate medication discontinuation compared with control by the end of the study. RESULTS: Fifty-eight articles met the study criteria. Thirty-three (58%) had a high risk of bias. Studies varied in duration from 4 weeks to 5 years and were conducted across a diverse array of primary health care settings. The most successful interventions used pharmacist-led educational interventions and patient-specific drug recommendations. Cardiovascular drugs including antihypertensives/diuretics and nitrates were the most successfully deprescribed class of drugs. Psychotropic medications and proton-pump inhibitors were the classes most resistant to deprescribing, despite intense intervention. CONCLUSIONS/IMPLICATIONS: Deprescription may be successful and effective in select classes of drugs, with collaboration of clinical pharmacists for patient and provider education, and patient-specific drug recommendations, complemented by close clinical follow-up to detect early signs of exacerbation of chronic diseases. This review also suggests that deprescription may (1) require expensive intensive, ongoing interventions by clinical teams; (2) not lead to expected outcomes such as improved falls rate, cognition, and quality of life, or a lower admission rate; and (3) have unexpected adverse outcomes affecting patients' quality of life.
引用
- Dills H, Shah K, Messinger-Rapport B, et al. Deprescribing Medications for Chronic Diseases Management in Primary Care Settings: A Systematic Review of Randomized Controlled Trials. J Am Med Dir Assoc. 2018. PMID: 30108032. doi:10.1016/j.jamda.2018.06.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。